Literature DB >> 19705676

Incarceration and opioid withdrawal: the experiences of methadone patients and out-of-treatment heroin users.

Shannon Gwin Mitchell1, Sharon M Kelly, Barry S Brown, Heather Schacht Reisinger, James A Peterson, Adrienne Ruhf, Michael H Agar, Robert P Schwartz.   

Abstract

Both heroin-addicted individuals and methadone maintenance patients are likely to face untreated opioid withdrawal while incarcerated. Limited research exists concerning the withdrawal experiences of addicted inmates and their impact on individuals' attitudes and plans concerning drug abuse treatment. In the present study, 53 opioid dependent adults (32 in methadone treatment and 21 out of treatment) were interviewed in an ethnographic investigation of withdrawal experiences during incarceration. When treatment for opioid withdrawal was unavailable, detoxification experiences were usually described as negative and were often associated with a variety of unhealthy behaviors designed to relieve withdrawal symptoms. Negative methadone withdrawal experiences also negatively influenced participants' receptivity to seeking methadone treatment upon release. A minority of participants took a positive view of their withdrawal experience and saw it as an opportunity to detox from heroin or discontinue methadone. Findings support the importance of providing appropriate opioid detoxification and/or maintenance therapy to opioid-dependent inmates.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19705676      PMCID: PMC2838492          DOI: 10.1080/02791072.2009.10399907

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  25 in total

1.  Attitudes and practices regarding the use of methadone in US state and federal prisons.

Authors:  Josiah D Rich; Amy E Boutwell; David C Shield; R Garrett Key; Michelle McKenzie; Jennifer G Clarke; Peter D Friedmann
Journal:  J Urban Health       Date:  2005-05-25       Impact factor: 3.671

2.  Incarceration, addiction and harm reduction: inmates experience injecting drugs in prison.

Authors:  Will Small; S Kain; Nancy Laliberte; Martin T Schechter; Michael V O'Shaughnessy; Patricia M Spittal
Journal:  Subst Use Misuse       Date:  2005       Impact factor: 2.164

3.  A syringe exchange programme in prison as prevention strategy against HIV infection and hepatitis B and C in Berlin, Germany.

Authors:  K Stark; U Herrmann; S Ehrhardt; U Bienzle
Journal:  Epidemiol Infect       Date:  2005-12-22       Impact factor: 2.451

Review 4.  Opioid addiction and incarceration: an overview.

Authors:  Robert P Schwartz; Michelle McKenzie; Josiah D Rich
Journal:  Med Health R I       Date:  2007-05

5.  Outbreak of HIV infection in a Scottish prison.

Authors:  A Taylor; D Goldberg; J Emslie; J Wrench; L Gruer; S Cameron; J Black; B Davis; J McGregor; E Follett
Journal:  BMJ       Date:  1995-02-04

6.  A 33-year follow-up of narcotics addicts.

Authors:  Y I Hser; V Hoffman; C E Grella; M D Anglin
Journal:  Arch Gen Psychiatry       Date:  2001-05

7.  In-treatment vs. out-of-treatment opioid dependent adults: drug use and criminal history.

Authors:  Robert P Schwartz; Sharon M Kelly; Kevin E O'Grady; James A Peterson; Heather S Reisinger; Shannon G Mitchell; Monique E Wilson; Michael H Agar; Barry S Brown
Journal:  Am J Drug Alcohol Abuse       Date:  2008       Impact factor: 3.829

8.  Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study.

Authors:  Marina Davoli; Anna M Bargagli; Carlo A Perucci; Patrizia Schifano; Valeria Belleudi; Matthew Hickman; Giuseppe Salamina; Roberto Diecidue; Federica Vigna-Taglianti; Fabrizio Faggiano
Journal:  Addiction       Date:  2007-12       Impact factor: 6.526

9.  A Study of Methadone Maintenance For Male Prisoners: 3-Month Postrelease Outcomes.

Authors:  Timothy W Kinlock; Michael S Gordon; Robert P Schwartz; Kevin E O'Grady
Journal:  Crim Justice Behav       Date:  2008

10.  Substance use and sexual behavior during incarceration among 18- to 29-year old men: prevalence and correlates.

Authors:  David Wyatt Seal; Andrew D Margolis; Kathleen M Morrow; Lisa Belcher; James Sosman; John Askew
Journal:  AIDS Behav       Date:  2007-03-08
View more
  25 in total

1.  Patient perspectives on buprenorphine/naloxone: a qualitative study of retention during the starting treatment with agonist replacement therapies (START) study.

Authors:  Cheryl Teruya; Robert P Schwartz; Shannon Gwin Mitchell; Albert L Hasson; Christie Thomas; Samantha H Buoncristiani; Yih-Ing Hser; Katharina Wiest; Allan J Cohen; Naomi Glick; Petra Jacobs; Paul McLaughlin; Walter Ling
Journal:  J Psychoactive Drugs       Date:  2014 Nov-Dec

2.  Forced withdrawal from methadone maintenance therapy in criminal justice settings: a critical treatment barrier in the United States.

Authors:  Jeannia J Fu; Nickolas D Zaller; Michael A Yokell; Alexander R Bazazi; Josiah D Rich
Journal:  J Subst Abuse Treat       Date:  2013-02-22

Review 3.  Linkage to care for HIV-infected heterosexual men in the United States.

Authors:  Nickolas D Zaller; Jeannia J Fu; Amy Nunn; Curt G Beckwith
Journal:  Clin Infect Dis       Date:  2011-01-15       Impact factor: 9.079

4.  Premature discharge from methadone treatment: patient perspectives.

Authors:  Heather Schacht Reisinger; Robert P Schwartz; Shannon Gwin Mitchell; James A Peterson; Sharon M Kelly; Kevin E O'Grady; Erica A Marrari; Barry S Brown; Michael H Agar
Journal:  J Psychoactive Drugs       Date:  2009-09

5.  Counseling Staff's Views of Patient-Centered Methadone Treatment: Changing Program Rules and Staff Roles.

Authors:  Shannon Gwin Mitchell; Laura B Monico; Elizabeth Lertch; Sharon M Kelly; Jan Gryczynski; Jerome H Jaffe; Kevin E O'Grady; Robert P Schwartz
Journal:  J Behav Health Serv Res       Date:  2018-07       Impact factor: 1.505

6.  Patient-centered methadone treatment: a randomized clinical trial.

Authors:  Robert P Schwartz; Sharon M Kelly; Shannon G Mitchell; Jan Gryczynski; Kevin E O'Grady; Devang Gandhi; Yngvild Olsen; Jerome H Jaffe
Journal:  Addiction       Date:  2016-11-10       Impact factor: 6.526

7.  Patient perspectives on choosing buprenorphine over methadone in an urban, equal-access system.

Authors:  Jan Gryczynski; Jerome H Jaffe; Robert P Schwartz; Kristi A Dušek; Nishan Gugsa; Cristin L Monroe; Kevin E O'Grady; Yngvild K Olsen; Shannon Gwin Mitchell
Journal:  Am J Addict       Date:  2013 May-Jun

8.  The impact of the opioid crisis on U.S. state prison systems.

Authors:  Christy K Scott; Michael L Dennis; Christine E Grella; Allison F Mischel; John Carnevale
Journal:  Health Justice       Date:  2021-07-24

9.  Leaving buprenorphine treatment: patients' reasons for cessation of care.

Authors:  Jan Gryczynski; Shannon Gwin Mitchell; Jerome H Jaffe; Kevin E O'Grady; Yngvild K Olsen; Robert P Schwartz
Journal:  J Subst Abuse Treat       Date:  2013-10-14

10.  "I Kicked the Hard Way. I Got Incarcerated." Withdrawal from Methadone During Incarceration and Subsequent Aversion to Medication Assisted Treatments.

Authors:  Jeronimo A Maradiaga; Shadi Nahvi; Chinazo O Cunningham; Jennifer Sanchez; Aaron D Fox
Journal:  J Subst Abuse Treat       Date:  2015-11-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.